CLS and University Hospital Magdeburg Begin Study of MRI-Ultrasound, Fusion-Guided Focal Laser Ablation Treatments of Prostate Cancer

Clinical Laserthermia Systems AB announced that its collaboration with Otto-von-Guericke-University Magdeburg, Medical faculty has obtained approval from the ethics committee, and from the responsible Competent Authority, in Germany. CLS and the Magdeburg medical team will now proceed with Investigator Initiated Trial regarding MRI-Ultrasound, fusion-guided focal laser ablation treatment of prostate cancer.